Caprock Group, Inc. Astrazeneca PLC Transaction History

Caprock Group, Inc.

$3 Billion
Q4 2024

A detailed history of Caprock Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Caprock Group, Inc. holds 27,729 shares of AZN stock, worth $2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

27,729

Previous 24,129 14.92%

Holding current value

$2 Million

Previous $1.88 Million 3.4%

% of portfolio

0.06%

Previous 0.07%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	BUY	$63.2 - $79.58 $227,520 - $286,488	3,600 Added 14.92%	27,729 $1.82 Million
Q3 2024 Nov 07, 2024	BUY	$76.67 - $87.62 $6,670 - $7,622	87 Added 0.36%	24,129 $1.88 Million
Q2 2024 Aug 06, 2024	BUY	$66.81 - $80.83 $908,081 - $1.1 Million	13,592 Added 130.07%	24,042 $1.88 Million
Q1 2024 Apr 29, 2024	BUY	$61.03 - $69.57 $75,616 - $86,197	1,239 Added 13.45%	10,450 $707,000
Q4 2023 Jan 18, 2024	SELL	$61.89 - $69.28 $117,343 - $131,354	-1,896 Reduced 17.07%	9,211 $620,000
Q3 2023 Oct 18, 2023	BUY	$64.85 - $71.7 $16,990 - $18,785	262 Added 2.42%	11,107 $752,000
Q2 2023 Aug 10, 2023	BUY	$69.91 - $75.81 $43,693 - $47,381	625 Added 6.12%	10,845 $776,000
Q1 2023 Apr 26, 2023	BUY	$63.15 - $71.6 $108,049 - $122,507	1,711 Added 20.11%	10,220 $709,000
Q4 2022 Jan 23, 2023	SELL	$54.21 - $70.44 $1,301 - $1,690	-24 Reduced 0.28%	8,509 $0
Q3 2022 Nov 07, 2022	SELL	$53.02 - $135.75 $49,255 - $126,111	-929 Reduced 9.82%	8,533 $468,000
Q2 2022 Jul 26, 2022	SELL	$59.26 - $71.14 $10,726 - $12,876	-181 Reduced 1.88%	9,462 $625,000
Q1 2022 Apr 12, 2022	BUY	$55.72 - $67.12 $167,995 - $202,366	3,015 Added 45.49%	9,643 $640,000
Q4 2021 Jan 18, 2022	SELL	$54.02 - $63.83 $104,042 - $122,936	-1,926 Reduced 22.52%	6,628 $386,000
Q3 2021 Oct 07, 2021	BUY	$55.56 - $60.79 $135,455 - $148,206	2,438 Added 39.86%	8,554 $514,000
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $265,971 - $330,568	-5,493 Reduced 47.32%	6,116 $366,000
Q1 2021 Apr 29, 2021	SELL	$47.16 - $54.44 $31,738 - $36,638	-673 Reduced 5.48%	11,609 $577,000
Q4 2020 Jan 29, 2021	BUY	$48.52 - $58.02 $107,277 - $128,282	2,211 Added 21.95%	12,282 $614,000
Q3 2020 Oct 29, 2020	BUY	$53.07 - $61.1 $59,809 - $68,859	1,127 Added 12.6%	10,071 $552,000
Q2 2020 Aug 05, 2020	SELL	$43.1 - $55.31 $7,025 - $9,015	-163 Reduced 1.79%	8,944 $473,000
Q1 2020 Apr 28, 2020	BUY	$37.79 - $51.33 $101,844 - $138,334	2,695 Added 42.03%	9,107 $407,000
Q4 2019 Feb 04, 2020	BUY	$42.46 - $50.46 $5,859 - $6,963	138 Added 2.2%	6,412 $320,000
Q3 2019 Oct 31, 2019	BUY	$40.12 - $45.47 $22,788 - $25,826	568 Added 9.95%	6,274 $280,000
Q2 2019 Jul 23, 2019	SELL	$37.28 - $41.68 $24,343 - $27,217	-653 Reduced 10.27%	5,706 $236,000
Q1 2019 Apr 12, 2019	BUY	$35.49 - $43.02 $22,855 - $27,704	644 Added 11.27%	6,359 $257,000
Q4 2018 Jan 29, 2019	BUY	$36.86 - $41.49 $210,654 - $237,115	5,715 New	5,715 $217,000

Others Institutions Holding AZN

# of Institutions

1,350

Shares Held

477M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $223B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account

Caprock Group, Inc. Astrazeneca PLC Transaction History